Curative Effect Observation of Burosumab for Children and Adults with X-Linked Hypophosphatemicrickets

We studied the patients diagnosed with X-linked hypophosphatemicrickets(XLH) and treated with burosumab in Peking Union Medical College Hospital from January 2021 to December 2022. In addition, we described the clinical characteristics of the patients, the changes of clinical indexes before and afte...

Full description

Bibliographic Details
Main Authors: LIU Qingyang, HOU Zijing, YANG Zixia, LIU Xin, ZHANG Bo, TANG Yan
Format: Article
Language:zho
Published: Editorial Office of Journal of Rare Diseases 2024-01-01
Series:罕见病研究
Subjects:
Online Access:https://jrd.chard.org.cn/article/doi/10.12376/j.issn.2097-0501.2024.01.014